fig1
![Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant](https://image.oaes.cc/70608cbc-7f9e-494a-b87e-152c1a1b5a7d/4557.fig.1.jpg)
Figure 1. Interplay between immune checkpoint inhibitors and liver transplant immunosuppression in a recipient with hepatocellular carcinoma, emphasizing the effect of these medications on components of the immune system. NK: Natural killer; IL: interleukin.